Marshall Wace
SNWV

Marshall Wace’s SANUWAVE Health Inc SNWV Stock Holding History

Marshall Wace’s Portfolio SNWV Stock Details SNWV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,657
Closed -$1.08M – 3306
2025
Q1 		$1.08M Buy
+30,657
New +$1.01M ﹤0.01% 1748

Other funds holding SNWV

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Marshall Wace's SNWV Position: Q2 2025 in Review

Marshall Wace sold out of SANUWAVE Health Inc (SNWV) in Q2 2025, closing a stake of 30,657 shares — an estimated $1.08M sold.

Marshall Wace first reported a position in SNWV in Q1 2025 and held it in 1 quarter. The position peaked at $1.08M in Q1 2025. 46 funds tracked by Wall St. Rank hold SNWV as of Q2 2025.

  • Marshall Wace reported no remaining SANUWAVE Health Inc position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 30,657 SANUWAVE Health Inc shares in Q2 2025, an estimated $1.08M.
  • Marshall Wace first reported a position in SANUWAVE Health Inc in Q1 2025 and held it in 1 quarter.
  • Marshall Wace's SANUWAVE Health Inc position peaked at $1.08M in Q1 2025.
  • 46 funds tracked by Wall St. Rank held SANUWAVE Health Inc as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.